Five Star Equities releases regular market updates so investors can stay ahead of the crowd and make the best investment decisions to maximize their returns. Take a few minutes to register with us free at www.FiveStarEquities.com and get exclusive access to our numerous stock reports.
Amyris Inc. (NASDAQ: AMRS) shares jumped 7.55 percent to close at $3.56 a share Thursday. The stock traded between $3.29 and $3.85 on volume 598,154 shares traded. The company is scheduled to report fourth quarter and full year 2013 results after market close on Tuesday, February 25th. Shares of Amyris are down approximately 32.0 percent year-to-date.
Get more information on Amyris and free access to the in-depth equity report at: www.FiveStarEquities.com/AMRS
Liberator Medical Holdings Inc. (NYSEMKT: LBMH) shares fell 11.60 percent to close at $4.04 a share Thursday. The stock traded between $3.79 and $4.55 on volume 1.60 million shares traded. The company reported net sales were $18.6 million for the first quarter of fiscal 2013, an increase of 6.2 percent when compared to a year ago. Shares of Liberator Medical are down approximately 3.0 percent year-to-date.
Get more information on Liberator Medical free access to the in-depth equity report at: www.FiveStarEquities.com/LBMH
The Medicines Company (NASDAQ: MDCO) shares dropped 11.54 percent to close at $29.28 a share Thursday. The stock traded between $28.00 and $29.57 on volume of 5.22 million shares traded. The company announced that the FDA’s Cardiovascular and Renal Drugs Advisory Committee has voted against approval of the intravenous antiplatelet agent cangrelor for use in patients undergoing percutaneous coronary intervention. Shares of The Medicines Company are down approximately 25.0 percent year-to-date.
Get more information on The Medicines Company and free access to the in-depth equity report at: www.FiveStarEquities.com/MDCO
VirnetX Holding Corporation (NYSEMKT: VHC) shares spiked 7.51 percent to close at $17.61 a share Thursday. The stock traded between $16.04 and $18.60 on volume of 1.35 million shares traded. The company announced that Patent Trial and Appeal Board have denied Apple, Inc.'s motions for a rehearing. Shares of VirnetX are down approximately 9.0 percent year-to-date.
Get more information on VirnetX and free access to the in-depth equity report at: www.FiveStarEquities.com/VHC
Disclaimer: Information, opinions and analysis contained herein are based on sources believed to be reliable, but no representation, expressed or implied, is made as to its accuracy, completeness or correctness. The opinions contained herein reflect our current judgment and are subject to change without notice. We accept no liability for any losses arising from an investor's reliance on or use of this report. This report is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. Certain information included herein is forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements concerning manufacturing, marketing, growth, and expansion. Such forward-looking information involves important risks and uncertainties that could affect actual results and cause them to differ materially from expectations expressed herein. Five Star Equities has no financial relationship with any company whose stock is mentioned in this release.
Contact: Five Star Equities [email protected]